Vimarsana
Biggest News Aggregation in the World

Page 45 - Clinical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Development Today - Breaking & Trending Today

Archer Daniels Midland : Gut Microbes Publishes ADM's New Clinical Study Showing Significant Improvements in IBS-SSS Scores and Quality of Life on Adults with IBS - Vimarsana News

Archer Daniels Midland : Gut Microbes Publishes ADM's New Clinical Study Showing Significant Improvements in IBS-SSS Scores and Quality of Life on Adults with IBS

CHICAGO-ADM , a leader in microbiome research and solutions, has announced the publication of a new study on probiotic Bifidobacterium longum CECT 7347 * and postbiotic heat-treated...

Changing women's healthcare: A look into Organon's mission and vision - Vimarsana News

Changing women's healthcare: A look into Organon's mission and vision

In the broad healthcare landscape, one area that has historically been overlooked and under-prioritized is women's health.

Valerio Therapeutics : Annual financial and audit reports / Terms of availability of the annual financial report - Vimarsana News

Valerio Therapeutics : Annual financial and audit reports / Terms of availability of the annual financial report

PRESS RELEASE Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development ...

Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients - Vimarsana News

Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients

The approval was based on data from an open-label clinical trial that included 33 virologically-suppressed pregnant adults.

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib - Vimarsana News

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib

- Pepper Bio will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib in the US, Europe, Japan, and All Other Global Markets Excluding...